HLAVNÍ TÉMA Antitrombotická léčba u antifosfolipidového syndromu, postavení přímých antikoagulancií 3. Uthman I, Noureldine MHA, Ruiz-Irastorza G, Khamashta M. Management of antiphospholipid syndrome. Ann Rheum Dis. 2019;78(2):155–161. 4. Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296–1304. 5. Tripodi A. Thrombin Generation Assay and Its Application in the Clinical Laboratory. Clin Chem. 2016;62(5):699–707. 6. Cohen H, Hunt BJ, Efthymiou M, et al. RAPS trial investigators. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial. Lancet Haematol. 2016;3(9):e426–436. 7. Pengo V, Denas G, Zoppellaro G. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood. 2018;132(13):1365–1371. 8. Pengo V, Hoxha A, Andreoli L, et al. Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes af ter the study closure. J Thromb Haemost. 2021;19(2):531–535. 9. Ordi-Ros J, Sáez-Comet L, Pérez-Conesa M, et al. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial. Ann Intern Med. 2019;171(10):685–694. 10. Goldhaber SZ, Eriksson H, Kakkar A, et al. Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™. Vasc Med. 2016;21(6):506–514. 11. Dufrost V, Wahl D, Zuily S. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials. Autoimmun Rev. 2021;20(1):102711. 12. Zuily S, Cohen H, Isenberg D, et al. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2020;18(9):2126–2137. 13. Moll S. How To Treat the Patients With Antiphospholipid Antibody Syndrome Who Need Anticoagulation? The Hematologist 2020;Vol.17:Issue 1. CLARION CONGRESS HOTEL PRAHA 18. - 21. 9. 2022 20TH INTERNATIONAL CONGRESS OF THERAPEUTIC DRUG MONITORING AND CLINICAL TOXICOLOGY IATDMCT PRAGUE 2022 BRIDGING THE TROUBLED WATERS www.iatdmct2022.org POZNAČTE SI DO KALENDÁŘE
RkJQdWJsaXNoZXIy NDA4Mjc=